Identifying Critical Data - The Foundation for Successful RBQM Adoption
Implementing Risk-based Quality Management (RBQM) in Clinical Trials starts with recognizing critical data. By attending this webinar, attendees will get a better...
Identifying Critical Data - The Foundation for Successful RBQM Adoption
Implementing Risk-based Quality Management (RBQM) in Clinical Trials starts with recognizing critical data. By attending this webinar, attendees will get a better...
Quality by Design - Integrating this into your technology platforms
An often-discussed topic Quality by Design can be understood and yet partially implemented. Data leaks and loss, quality and compliance challenges, and managing data...
State of the CDM Industry: The SCDM Chair Address
During the State of the CDM Industry webinar - part of SCDM's Leadership Webinar Series - SCDM's Chair for 2023, Arshad Mohammed, delivers this must watch session...
2022 Annual Conference - Regulatory Panel
This SCDM 2022 Regulatory Town Hall, a conference favorite, included both US and European regulatory officials. The town hall speakers are representatives from the...
Best of #SCDM2022: Highlights from SCDM's recent Annual Conference
During the Best of #SCDM2022 webinar - part of SCDM's Leadership Webinar Series - SCDM leaders will look back at the main discussion and topics covered during our most...
A journey through drug development in four phases - A CDM perspective: Clinical Trials Phase I
While all phases of clinical research have safety as a primary objective, phase I clinical trials focus on initial safety and tolerability to determine an appropriate...
A journey through drug development in four phases - A CDM perspective: Clinical Trials Phase IV
This webinar will explore Phase IV post-marketing studies and will take you on a journey of continued drug development following regulatory approval. This last phase...
A journey through drug development in four phases - A CDM perspective: Clinical Trials Phases II & III
This webinar will explore Phase I/II, Phase II and Phase III clinical trials. FDA definitions of Phase II and Phase III trials will be the basis for the discussion....
A Site Centric Design Approach to Designing Clinical Data Management Software
Traditional clinical data management tools often don’t take into account how important sites are for collecting clean and robust trial data. During this webinar we...
Impact of the Clinical Data Science (CDS) Role Evolution on Business Models
Transforming your Business Models when evolving your organization into a Clinical Data Science (CDS) function is NOT optional but imperative to success of future...
Careers in Clinical Data Management and an Introduction to the Society of Clinical Data Management (SCDM)
This session aims to share guidance on careers in clinical data management for new graduates. Speakers from the SCDM Board of Trustees will be sharing information...
MedDRA Training for Data Managers and Associate Roles: How is MedDRA used for analysis?
Introduction to MedDRA in relation to Medical coding and the Analysis of Data will take participants on a journey through the features of MedDRA and the associated...
MedDRA Training for Data Managers and Associate Roles: How is MedDRA used for coding?
Introduction to MedDRA in relation to Medical coding and the Analysis of Data will take participants on a journey through the features of MedDRA and the associated...
MedDRA Training for Data Managers and Associate Roles: What is MedDRA and the MSSO?
Introduction to MedDRA in relation to Medical coding and the Analysis of Data will take participants on a journey through the features of MedDRA and the associated...
How Organizations are Leveraging Standardization in Clinical Trial Design & Build
Standardization is an integral step in improving and modernizing the clinical trial design and build process. But how are organizations achieving standardization? What...